Relaxin Enhances the Oncogenic Potential of Human Thyroid Carcinoma Cells
- 1 August 2006
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 169 (2) , 617-632
- https://doi.org/10.2353/ajpath.2006.050876
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Catalytically inactive human cathepsin D triggers fibroblast invasive growthThe Journal of cell biology, 2005
- Cathepsin V, a Novel and Potent Elastolytic Activity Expressed in Activated MacrophagesJournal of Biological Chemistry, 2004
- Complex roles of tissue inhibitors of metalloproteinases in cancerOncogene, 2002
- Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: Effects on the invasive phenotypeCancer Gene Therapy, 2001
- Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinomaCancer, 2000
- Relaxin Binds to and Elicits a Response from Cells of the Human Monocytic Cell Line, THP-1Published by Elsevier ,1996
- Recombinant porcine prorelaxin produced in Chinese hamster ovary cells is biologically activeLife Sciences, 1993
- LEUCOCYTE MIGRATION INHIBITION IN VITRO WITH INHIBITORS OF ASPARTIC AND SULPHHYDRYL PROTEINASESActa Pathologica Microbiologica Scandinavica Series C: Immunology, 1984
- EFFECT OF RELAXIN ON THYROID FUNCTION IN THE RATJournal of Endocrinology, 1963
- THE EFFECT OF RELAXIN ON THYROID WEIGHTS IN LABORATORY ANIMALSJournal of Endocrinology, 1960